Among adults with COPD and type 2 inflammation, having a history of cardiovascular or metabolic disease did not change ...
Prescribing inhalers offers physicians a chance to impact climate change — but switching to greener options comes with ...
Receiving dupilumab for 52 weeks lowered the risk for severe exacerbations vs. placebo in adults with COPD and type 2 ...
PsyPost on MSN
Early-life sugar restriction is linked to lower adult asthma and COPD risk, study finds
A new study suggests that restricting sugar intake during pregnancy and the first two years of a child’s life is associated ...
New findings from the ERS Global Congress on Lung Diseases present a paradigm shift in COPD treatment: Early identification of type 2 inflammation and personalized biologic therapy.
AstraZeneca's hopes of a big new indication for respiratory drug Fasenra in chronic obstructive pulmonary disease (COPD) have been dashed by a negative phase 3 trial. The RESOLUTE study of IL-5 ...
Mayo Clinic researchers have identified a molecular "switch" in lung cells that helps them decide when to repair tissue and ...
Prior COVID-19 infection was not independently associated with an increased risk for upper respiratory tract infections in adults.
Nirmatrelvir-ritonavir reduced the risk for long COVID in adults aged 50 years and older but not in adolescents.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback